Literature DB >> 3144942

Diagnostic and therapeutic problems in two patients with antiphospholipid antibodies, heart valve lesions, and transient ischaemic attacks.

R A Asherson1, D G Gibson, D W Evans, E Baguley, G R Hughes.   

Abstract

Two young women (aged 32 and 25 years) with systemic lupus erythematosus and heart valve lesions in association with antiphospholipid antibodies are presented. In addition to the presence of the 'lupus anticoagulant' and false positive Venereal Disease Research Laboratory (VDRL) tests, both patients had high levels of IgG anticardiolipin antibodies. The first patient additionally had contraceptive induced chorea, chorea gravidarum, seven miscarriages, livedo reticularis, pulmonary embolism, and thrombocytopenia and developed culture negative endocarditis as well as hypertension. The second patient, who had presented with hypertension, developed aortic and mitral regurgitation, suspected myocarditis, manifested transient ischaemic attacks, and responded well to anticoagulation and steroid treatment.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3144942      PMCID: PMC1003638          DOI: 10.1136/ard.47.11.947

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  35 in total

1.  Mitral valve disease of systemic lupus erythematosus. A cause of severe congestive heart failure reversed by valve replacement.

Authors:  S A Paget; B H Bulkley; L E Grauer; R Seningen
Journal:  Am J Med       Date:  1975-07       Impact factor: 4.965

2.  Aortic regurgitation in systemic lupus erythematosus requiring aortic valve replacement.

Authors:  W M Oh; R T Taylor; G J Olsen
Journal:  Br Heart J       Date:  1974-04

3.  Mitral valve replacement for mitral regurgitation due to Libman-Sacks endocarditis. Report of a case.

Authors:  P D Myerowitz; L L Michaelis; C L McIntosh
Journal:  J Thorac Cardiovasc Surg       Date:  1974-06       Impact factor: 5.209

4.  Acute mitral regurgitation from ruptured chordae tendineae in systemic lupus erythematosus.

Authors:  F T Murray; D S Fuleihan; C S Cornwall; R S Pinals
Journal:  J Rheumatol       Date:  1975-12       Impact factor: 4.666

5.  Systemic lupus erythematosus as a cause of severe mitral regurgitation. New problem in an old disease.

Authors:  B H Bulkey; W C Roberts
Journal:  Am J Cardiol       Date:  1975-02       Impact factor: 2.778

6.  Severe aortic incompetence caused by systemic lupus erythematosus. A case report.

Authors:  F T Thandroyen; R E Matisonn; E K Weir
Journal:  S Afr Med J       Date:  1978-07-22

7.  Immunopathogenesis of Libman-Sacks endocarditis. Assessment by light and immunofluorescent microscopy in two patients.

Authors:  R F Shapiro; C N Gamble; K B Wiesner; J J Castles; A W Wolf; E J Hurley; A F Salel
Journal:  Ann Rheum Dis       Date:  1977-12       Impact factor: 19.103

8.  The myocarditis of systemic lupus erythematosus: association with myositis.

Authors:  D G Borenstein; W B Fye; F C Arnett; M B Stevens
Journal:  Ann Intern Med       Date:  1978-11       Impact factor: 25.391

9.  Mitral valve replacement for mitral stenosis caused by Libman-Sacks endocarditis.

Authors:  K C Vaughton; D R Walker; M F Sturridge
Journal:  Br Heart J       Date:  1979-06

10.  Cerebral embolism in Libman-Sacks endocarditis.

Authors:  I S Fox; A M Spence; R F Wheelis; L A Healey
Journal:  Neurology       Date:  1980-05       Impact factor: 9.910

View more
  13 in total

Review 1.  Estrogen as neuroprotectant of nigrostriatal dopaminergic system: laboratory and clinical studies.

Authors:  Dean Dluzen; Martin Horstink
Journal:  Endocrine       Date:  2003-06       Impact factor: 3.633

Review 2.  The antiphospholipid syndrome: a syndrome in evolution.

Authors:  R A Asherson; R Cervera
Journal:  Ann Rheum Dis       Date:  1992-02       Impact factor: 19.103

3.  Chorea in primary antiphospholipid syndrome is associated with rheumatic fever.

Authors:  Simone Appenzeller; Steeven Yeh; Marcelo Maruyama; Solange Murta Barros; Jozélio Freire de Carvalho
Journal:  Rheumatol Int       Date:  2011-09-01       Impact factor: 2.631

4.  Heart valve disease in systemic lupus erythematosus. Role of antiphospholipid antibodies.

Authors:  O Meyer; M Golstein; P Nicaise; C Labarre; M F Kahn
Journal:  Clin Rev Allergy Immunol       Date:  1995       Impact factor: 8.667

5.  Infective endocarditis, rheumatoid factor, and anticardiolipin antibodies.

Authors:  R A Asherson; M Tikly; H Staub; P T Wilmshurst; D J Coltart; M Khamashta; G R Hughes
Journal:  Ann Rheum Dis       Date:  1990-02       Impact factor: 19.103

6.  The heart in systemic lupus erythematosus.

Authors:  R A Barker
Journal:  BMJ       Date:  1989-07-22

7.  Antiphospholipid antibodies, lupus-like disease and the "primary" antiphospholipid syndrome.

Authors:  R A Asherson; M A Khanashta; G R Hughes
Journal:  Clin Rheumatol       Date:  1989-03       Impact factor: 2.980

8.  Cardiac disease in systemic lupus erythematosus: prospective study of 70 patients.

Authors:  R Cervera; J Font; C Paré; M Azqueta; F Pérez-Villa; A López-Soto; M Ingelmo
Journal:  Ann Rheum Dis       Date:  1992-02       Impact factor: 19.103

Review 9.  Movement disorders in systemic lupus erythematosus and the antiphospholipid syndrome.

Authors:  José Fidel Baizabal-Carvallo; Cecilia Bonnet; Joseph Jankovic
Journal:  J Neural Transm (Vienna)       Date:  2013-04-13       Impact factor: 3.575

10.  Cardiac valvular disease in patients with systemic lupus erythematosus. Relationship with anticardiolipin antibodies.

Authors:  Piotr Leszczyński; Ewa Straburzyńska-Migaj; Izabela Korczowska; Jan K Łacki; Stefan Mackiewicz
Journal:  Clin Rheumatol       Date:  2003-10-14       Impact factor: 2.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.